EDTA Eye Drops Compared to Abreva for Herpes Simplex Virus Eruptions
Condition: Herpes Simplex Oral Interventions: Drug: EDTA; Drug: Abreva Sponsor: University of Utah Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 19, 2021 Category: Research Source Type: clinical trials
A Study on the Reactogenicity, Safety and Immune Response of a Vaccine Against Herpes Simplex Virus (HSV)-2 in Healthy Participants Aged 18-40 Years
Condition: Herpes Simplex Interventions: Biological: Lower dose formulation of HSV vaccine (GSK4108771A); Biological: Low dose formulation of HSV vaccine (GSK4108771A); Biological: Medium dose formulation of HSV vaccine (GSK4108771A); Biological: High dose formulation of HSV vaccine (GSK4108771A); Drug: Placebo (saline) Sponsor: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2021 Category: Research Source Type: clinical trials